Evaluation of six clinical prognostic scores in NSCLC patients undergoing first line chemoimmunotherapy
The RMH, MDACC, and MDACC+NLR scoring systems all demonstrate prognostic utility in the NSCLC patients treated with first-line CIT, and the optimal choice among them may depend on the specific clinical context and the outcome metric of primary interest.
Authors
- Zhisong Fan
- Jiayin Liu (ORCID: https://orcid.org/0000-0001-9237-0823)
- Jiaqi Sun (ORCID: https://orcid.org/0000-0002-5931-0578)
- Yuxing Wang (ORCID: https://orcid.org/0000-0003-3079-5572)
- Long Wang
- Xinliang Zhou
- Jing Zuo
- Jing Han
- Xue Zhang
- Lan Wang
- Li Feng
- Dan Li
Institutions
- Hebei Medical University (CN)
- Fourth Hospital of Hebei Medical University (CN)
- Aerospace Center Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-02-17
- DOI
- https://doi.org/10.3389/fimmu.2026.1695859
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Beijing Xisike Clinical Oncology Research Foundation
- Natural Science Foundation of Hebei Province
- Hebei Medical University